341 related articles for article (PubMed ID: 28526501)
1. Hypoxia modulates cell migration and proliferation in placenta-derived mesenchymal stem cells.
Li L; Jaiswal PK; Makhoul G; Jurakhan R; Selvasandran K; Ridwan K; Cecere R
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):543-552.e3. PubMed ID: 28526501
[TBL] [Abstract][Full Text] [Related]
2. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
[TBL] [Abstract][Full Text] [Related]
3. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin increases the motility of human bone marrow-multipotent stromal cells (hBM-MSCs) and enhances the production of neurotrophic factors from hBM-MSCs.
Koh SH; Noh MY; Cho GW; Kim KS; Kim SH
Stem Cells Dev; 2009 Apr; 18(3):411-21. PubMed ID: 18590375
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1α in MSCs.
Liu H; Xue W; Ge G; Luo X; Li Y; Xiang H; Ding X; Tian P; Tian X
Biochem Biophys Res Commun; 2010 Oct; 401(4):509-15. PubMed ID: 20869949
[TBL] [Abstract][Full Text] [Related]
6. Direct GSK-3β inhibition enhances mesenchymal stromal cell migration by increasing expression of β-PIX and CXCR4.
Kim YS; Noh MY; Kim JY; Yu HJ; Kim KS; Kim SH; Koh SH
Mol Neurobiol; 2013 Apr; 47(2):811-20. PubMed ID: 23288365
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride.
Liu L; Yu Q; Fu S; Wang B; Hu K; Wang L; Hu Y; Xu Y; Yu X; Huang H
Stem Cells Dev; 2018 Apr; 27(7):466-478. PubMed ID: 29433375
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1alpha/CXCR4 signaling axis.
Li M; Yu J; Li Y; Li D; Yan D; Qu Z; Ruan Q
Exp Mol Pathol; 2010 Apr; 88(2):250-5. PubMed ID: 20025867
[TBL] [Abstract][Full Text] [Related]
9. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation.
Bhakta S; Hong P; Koc O
Cardiovasc Revasc Med; 2006; 7(1):19-24. PubMed ID: 16513519
[TBL] [Abstract][Full Text] [Related]
10. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion.
Liu X; Duan B; Cheng Z; Jia X; Mao L; Fu H; Che Y; Ou L; Liu L; Kong D
Protein Cell; 2011 Oct; 2(10):845-54. PubMed ID: 22058039
[TBL] [Abstract][Full Text] [Related]
11. Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI).
Ling L; Hou J; Liu D; Tang D; Zhang Y; Zeng Q; Pan H; Fan L
Stem Cell Res Ther; 2022 Feb; 13(1):79. PubMed ID: 35197118
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4.
Barhanpurkar-Naik A; Mhaske ST; Pote ST; Singh K; Wani MR
Stem Cell Res Ther; 2017 Jul; 8(1):168. PubMed ID: 28705238
[TBL] [Abstract][Full Text] [Related]
13. Deferoxamine preconditioning potentiates mesenchymal stem cell homing in vitro and in streptozotocin-diabetic rats.
Najafi R; Sharifi AM
Expert Opin Biol Ther; 2013 Jul; 13(7):959-72. PubMed ID: 23536977
[TBL] [Abstract][Full Text] [Related]
14. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.
Gao H; Priebe W; Glod J; Banerjee D
Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687
[TBL] [Abstract][Full Text] [Related]
15. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
[TBL] [Abstract][Full Text] [Related]
16. Trafficking mechanism of bone marrow-derived mesenchymal stem cells toward hepatocellular carcinoma HepG2 cells by modulating Endoglin, CXCR4 and TGF-β.
Mardomi A; Sabzichi M; Hussein Somi M; Shanehbandi D; Rahbarghazi R; Taj Sanjarani O; Samadi N
Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):81-86. PubMed ID: 27755957
[TBL] [Abstract][Full Text] [Related]
17. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases.
Son BR; Marquez-Curtis LA; Kucia M; Wysoczynski M; Turner AR; Ratajczak J; Ratajczak MZ; Janowska-Wieczorek A
Stem Cells; 2006 May; 24(5):1254-64. PubMed ID: 16410389
[TBL] [Abstract][Full Text] [Related]
18. SDF-1α/CXCR4 Axis Mediates The Migration of Mesenchymal Stem Cells to The Hypoxic-Ischemic Brain Lesion in A Rat Model.
Yu Q; Liu L; Lin J; Wang Y; Xuan X; Guo Y; Hu S
Cell J; 2015; 16(4):440-7. PubMed ID: 25685734
[TBL] [Abstract][Full Text] [Related]
19. SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway.
Xiu G; Li X; Yin Y; Li J; Li B; Chen X; Liu P; Sun J; Ling B
Cell Transplant; 2020; 29():963689720929992. PubMed ID: 32452221
[TBL] [Abstract][Full Text] [Related]
20. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt.
Yu J; Li M; Qu Z; Yan D; Li D; Ruan Q
J Cardiovasc Pharmacol; 2010 May; 55(5):496-505. PubMed ID: 20179608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
